Home > Financial Ratios > SUVEN PHARMACEUTICALS

SUVEN PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
SUVEN PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for SUVEN PHARMACEUTICALS
Please provide your vote to see the results

SUVEN PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 36.8019.3923.4127.876.79

What is the latest EV/Core EBITDA ratio of SUVEN PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of SUVEN PHARMACEUTICALS is 36.80 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202436.80
Mar202319.39
Mar202223.41
Mar202127.87
Mar20206.79

How is EV/Core EBITDA of SUVEN PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2024 36.8
89.79
Mar2023 19.39
-17.17
Mar2022 23.41
-16.00
Mar2021 27.87
310.46
Mar2020 6.79 -

Other Financial Ratios of SUVEN PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of SUVEN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUVEN PHARMACEUTICALS ₹29,733.5 Cr 10.7% 3.4% 92.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,136.0 Cr 0.2% 1% 6.3% Stock Analytics
DIVIS LABORATORIES ₹149,680.0 Cr 6.8% 1.6% 53.3% Stock Analytics
CIPLA ₹122,390.0 Cr 4.4% 2.9% 4.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,159.0 Cr -0.7% 4% 25.1% Stock Analytics
DR REDDYS LABORATORIES ₹97,105.6 Cr 4.6% 4.9% -6.2% Stock Analytics


SUVEN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SUVEN PHARMACEUTICALS

10.7%

3.4%

92.3%

SENSEX

5.8%

6.1%

4.7%


You may also like the below Video Courses